To further confirm the role of HDAC3 in the increased H3K9 acetylation observed in IPF fibroblasts, we treated control fibroblasts with RGFP966, a highly selective HDAC3 activity inhibitor with an IC50 of 80 nM [21]. This evidence concerns the gene HDAC3 and idiopathic pulmonary fibrosis.